18F-Fluorodeoxiglucose Positron Emission Tomography for the Evaluation of Neoadjuvant Therapy Response in Esophageal Cancer

200965 citationsReview

Authors

Á.C. Rebollo Aguirre · Hospital Universitario Virgen de las Nieves

C. Ramos-Font · Hospital Universitario Virgen de las Nieves

Román Villegas · Andalusian Agency for Healthcare Quality

Gary Cook · Royal Marsden Hospital

J.M. Llamas Elvira · Hospital Universitario Virgen de las Nieves

Antonio Romero-Tabares · Andalusian Agency for Healthcare Quality

Abstract

FDG-PET seems to be the best available imaging modality for neoadjuvant therapy response assessment in esophageal cancer. But more prospective studies with larger populations are needed to confirm the power of this imaging tool in this aim and to determine the best analytical interpretation method and threshold to differentiate responders from nonresponding patients.

Topics & Keywords

Esophageal Cancer Research and Treatment Lung Cancer Diagnosis and Treatment Gastric Cancer Management and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Surgery

Volume 250, Issue 2, pp. 247-254

DOI: 10.1097/sla.0b013e3181b0c3a6

Field-Weighted Citation Impact: 6.86